Lauren Ritterhouse
Overview
Explore the profile of Lauren Ritterhouse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
304
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skoulidis F, Araujo H, Do M, Qian Y, Sun X, Cobo A, et al.
Nature
. 2025 Feb;
639(8054):E19.
PMID: 40016449
No abstract available.
2.
Skoulidis F, Araujo H, Do M, Qian Y, Sun X, Cobo A, et al.
Nature
. 2024 Oct;
635(8038):462-471.
PMID: 39385035
For patients with advanced non-small-cell lung cancer (NSCLC), dual immune checkpoint blockade (ICB) with CTLA4 inhibitors and PD-1 or PD-L1 inhibitors (hereafter, PD-(L)1 inhibitors) is associated with higher rates of...
3.
Sholl L, Awad M, Roy U, Beasley M, Cartun R, Hwang D, et al.
Arch Pathol Lab Med
. 2024 Apr;
148(7):757-774.
PMID: 38625026
Context.—: Rapid advancements in the understanding and manipulation of tumor-immune interactions have led to the approval of immune therapies for patients with non-small cell lung cancer. Certain immune checkpoint inhibitor...
4.
Thierauf J, Kaluziak S, Codd E, Dybel S, Jobbagy S, Purohit R, et al.
Pigment Cell Melanoma Res
. 2023 Jun;
36(5):378-387.
PMID: 37390098
Mucosal melanoma (MM) is a rare subtype of melanoma with an aggressive clinical course. In cutaneous melanoma (CM), the absence of pigmentation and presence of NRAS/KRAS mutations are biomarkers indicating...
5.
Sweis R, Heiss B, Segal J, Ritterhouse L, Kadri S, Churpek J, et al.
JCO Precis Oncol
. 2022 Feb;
2:1-7.
PMID: 35135165
No abstract available.
6.
Parilla M, Chapel D, Hechtman J, Wanjari P, Jabbour T, Sharma A, et al.
Am J Surg Pathol
. 2022 Feb;
46(6):823-831.
PMID: 35125451
Chromosomal aneuploidies are prognostic markers across a wide variety of tumor types, and recent literature suggests that pancreatic neuroendocrine tumors are no different. In this study 214 patients with grade...
7.
Gallan A, Parilla M, Segal J, Ritterhouse L, Antic T
Am J Clin Pathol
. 2020 Nov;
155(5):718-728.
PMID: 33210135
Objectives: While aberrations in the VHL gene and chromosome 3p resulting in clear cell renal cell carcinoma (CCRCC) are well established, we know that additional mutations in chromatin remodeling genes...
8.
Setia N, Wanjari P, Yassan L, Niu N, Kadri S, Ritterhouse L, et al.
Hum Pathol
. 2019 Nov;
97:103-111.
PMID: 31783043
The molecular alterations identified among pyloric gland adenomas (PGAs) in the published literature are based on polymerase chain reaction of targeted genes, and next-generation sequencing (NGS) has not been performed....
9.
Choudhury N, Eghtesad M, Kadri S, Cursio J, Ritterhouse L, Segal J, et al.
Oncotarget
. 2019 Oct;
10(56):5817-5823.
PMID: 31645901
Black patients have been historically underrepresented in studies investigating molecular patterns in non-small cell lung cancer (NSCLC). We aimed to investigate differences in actionable mutations among patients at our urban,...
10.
Tolaney S, Guo H, Pernas S, Barry W, Dillon D, Ritterhouse L, et al.
J Clin Oncol
. 2019 Apr;
37(22):1868-1875.
PMID: 30939096
Purpose: The Adjuvant Paclitaxel and Trastuzumab trial was designed to address treatment of patients with small human epidermal growth factor receptor 2 (HER2)-positive breast cancer. The primary analysis of the...